-
Signature
-
/s/ Christian Kuhlen, attorney-in-fact
-
Issuer symbol
-
ORIC
-
Transactions as of
-
06 Oct 2025
-
Net transactions value
-
-$111,759
-
Form type
-
4
-
Filing time
-
08 Oct 2025, 17:37:17 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Piscitelli Dominic |
Chief Financial Officer |
C/O ORIC PHARMACEUTICALS, INC., 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO |
/s/ Christian Kuhlen, attorney-in-fact |
08 Oct 2025 |
0001695028 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ORIC |
Common Stock |
Options Exercise |
$47,960 |
+11,000 |
+23% |
$4.36 |
59,317 |
06 Oct 2025 |
Direct |
|
| transaction |
ORIC |
Common Stock |
Sale |
$159,719 |
-11,000 |
-19% |
$14.52 |
48,317 |
06 Oct 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ORIC |
Stock Option (right to buy) |
Options Exercise |
$0 |
-11,000 |
-5.3% |
$0.000000 |
196,500 |
06 Oct 2025 |
Common Stock |
11,000 |
$4.36 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: